Get a clear sense of how your body responds to it before introducing additional compounds
We need a clinical trial to know whether these SGLT2 inhibitors and GLP-1 receptor agonists could actually change practice, how we can help patients to prevent a second or recurrent stroke
K., Cristofaro, V., & Sullivan, M
If you have limited subcutaneous fat in your arms due to low body weight or significant weight loss, discuss alternative injection sites with your healthcare provider, as the abdomen or thigh may be more appropriate
Only certain oral formulations are FDA-approved (for example, Rybelsus for diabetes), and many oral products sold as drops are compounded, not FDA-approved, and lack the clinical testing required to confirm safety and dose